Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,737.78
(
-0.24%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.38
(
-2.06%
)
Bitcoin
70,379.25
(
-1.21%
)
News Focus
News Focus
Post# of 257261
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122801
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: oc631 post# 127273

Saturday, 09/24/2011 12:43:36 PM

Saturday, September 24, 2011 12:43:36 PM

Post# of 257261
Maybe, but I rather doubt it. LLY and AZN are badly out of favor with investors—even more so than other Big Pharma. If LLY and AZN were indeed working on FoB’s—or had the intention of doing do—one would think they would have found a way to mention this at some investor presentation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now